Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Biocept Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 30 | 29 | −1 |
| Shares | 2.11M | 1.90M | −214.5K (−10.2%) |
| Value | $4.90M | $1.78M | −$3.12M (−63.6%) |
New holders (6)
Institutions that held Biocept Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 103,124 | $97.0K | 0.00% |
| Virtu Financial LLC | 28,201 | $27.0K | 0.00% |
| Jane Street Group, LLC | 14,072 | $13.0K | 0.00% |
| Simplex Trading, LLC | 5,753 | $5.00K | 0.00% |
| Castle Wealth Management LLC | 1,350 | $1.00K | 0.00% |
| FMR LLC | 2 | $0 | 0.00% |
Sold out (7)
Institutions that held Biocept Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Marshall Wace, LLP | 92,810 | $215.0K |
| JPMorgan Chase & Co | 81,367 | $189.0K |
| PDT Partners, LLC | 35,646 | $83.0K |
| UBS Group AG | 2,143 | $5.00K |
| Morgan Stanley | 1,900 | $4.00K |
| Kayne Anderson Rudnick Investment Management LLC | 9 | $0 |
| Glassman Wealth Services | 1 | $0 |